Pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the Schedule of Analyst or Institutional Meetings with the Company.
The above information is a part of company’s filings submitted to BSE.